Dean J Mitchell Praxis Precision Medicines, Inc. (PRAX) insider trading activity

PRAX Quotes by TradingView

Dean J Mitchell is Director of Praxis Precision Medicines, Inc.. Currently has a direct ownership of 75,000 shares of PRAX, which is worth approximately $5.25 Million. The most recent transaction as insider was on Mar 24, 2023, when has been sold 50,000 shares (Common Stock) at a price of $0.84 per share, resulting in proceeds of $42,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75K
0% 3M change
0% 12M change
Total Value Held $5.25 Million

DEAN J MITCHELL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 24 2023
BUY
Open market or private purchase
$42,000 $0.84 p/Share
50,000 Added 40.0%
75,000 Common Stock
Jun 08 2022
BUY
Open market or private purchase
$45,250 $1.81 p/Share
25,000 Added 50.0%
25,000 Common Stock

Also insider at

IMGN
ImmunoGen, Inc. Healthcare
Director
PGEN
PRECIGEN, INC. Healthcare
Director
TBPH
Theravance Biopharma, Inc. Healthcare
KNTE
Kinnate Biopharma Inc. Healthcare
DJM

Dean J Mitchell

Director
Waltham, MA

Track Institutional and Insider Activities on PRAX

Follow Praxis Precision Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRAX shares.

Notify only if

Insider Trading

Get notified when an Praxis Precision Medicines, Inc. insider buys or sells PRAX shares.

Notify only if

News

Receive news related to Praxis Precision Medicines, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PRAX